The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the available information, a cause for the reported pericardial effusion could not be determined.The reported cardiac tamponade and hypotension appear to have been cascading events of the reported pericardial effusion.The reported patient effects of pericardial effusion, cardiac tamponade, and hypotension, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention and required medication were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
|
This is being filed to report during the procedure, a pre-existing pericardial effusion worsened requiring medical intervention.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with grade 4.The steerable guide catheter (sgc) was advanced without issue and just when the clip delivery system (cds) was coming out of the sgc, a pericardial effusion was noted, and blood pressure dropped.Pericardiocentesis was performed and medication was administered for the blood pressure drop and the patient was stabilized.The procedure was aborted, and procedure rescheduled for another day.No additional information was provided.
|